Pharmaceuticals (Basel) October 2021 PMID 34832872

Umbilical Cord-Derived Wharton's Jelly for Regenerative Medicine Applications: A Systematic Review.

Benjamin J Main, Nicola Maffulli, Josiah A Valk, Hugo C Rodriguez, Manu Gupta, Saadiq F El-Amin, Ashim Gupta

Download social card

Mentions

6
Peak: 2 in Oct 2021
across 2 sources since Feb 2020

Extended reach

12,076
potential audience

Total likes

25

Video views

929

Mentions per month

Feb 2020 – Dec 2023

Where it's discussed

  • X / Twitter4 posts
  • YouTube2 videos

AI synopsis

What people are saying

The overall sentiment reflects mild interest and neutral engagement, with examples like posts sharing the article’s basic details and references to recent studies, using phrases such as 'latest study' and 'systematic review.' The tone remains informational without much personal commentary or critical discussion, which contributes to the scores indicating limited agreement and impact.

AgreementNeither agree nor disagree

Most discussions mainly acknowledge or share the publication without expressing strong opinions or disagreements.

InterestModerate interest

The posts show some curiosity, particularly by sharing news about the research, but lack deep analysis or enthusiasm.

EngagementNeutral engagement

Conversations are limited to sharing links or brief mentions, indicating surface-level engagement rather than in-depth discussion.

ImpactNeutral impact

There is no clear indication that these discussions are influencing opinion or practice significantly, as they mostly consist of acknowledgments.

Abstract in brief

  • Musculoskeletal issues affect millions globally and strain healthcare systems, prompting a search for better treatment options.
  • Research highlights mesenchymal stem cells (MSCs), particularly Wharton's jelly-derived MSCs (WJSCs), as promising alternatives to traditional therapies.
  • A systematic review of studies from 2010 to 2021 indicates WJSCs could benefit various orthopedic conditions, but further randomized controlled trials are needed to ensure their safety and effectiveness.

Top posts

Most liked on X and Bluesky
Pharmaceuticals MDPI
@Pharmaceut_MDPI · X

In case you have missed it, here is the #published article on our #Pharmaceuticals

Dec 4, 2023 · 1 like · 1,843 followers View post →
SystematicReviewBot
@EvidenceRobot · X

RT @myjournals: Pharmaceuticals, Vol. 14, Pages 1090: Umbilical Cord-Derived Wharton`s Jelly for Regenerative Medicine Applications: A Syst…

Oct 27, 2021 · 1 share · 6,711 followers View post →
Umbilical & Placental Cell News
@Cord_Blood_News · X

Latest study from @UniSalerno: Umbilical cord-derived Wharton’s jelly for regenerative medicine applications. https://t.co/yeuCMf5FvG

Feb 21, 2020 · 2,034 followers View post →
MyJournals
@myjournals · X

Pharmaceuticals, Vol. 14, Pages 1090: Umbilical Cord-Derived Wharton`s Jelly for Regenerative Medicine Applications: A Systematic Review https://t.co/OQtxAgbJSe

Oct 27, 2021 · 1 share · 556 followers View post →

All mentions

Pharmaceuticals MDPI
@Pharmaceut_MDPI · X

In case you have missed it, here is the #published article on our #Pharmaceuticals

Dec 4, 2023 · 1 like · 1,843 followers View post →
SystematicReviewBot
@EvidenceRobot · X

RT @myjournals: Pharmaceuticals, Vol. 14, Pages 1090: Umbilical Cord-Derived Wharton`s Jelly for Regenerative Medicine Applications: A Syst…

Oct 27, 2021 · 1 share · 6,711 followers View post →
MyJournals
@myjournals · X

Pharmaceuticals, Vol. 14, Pages 1090: Umbilical Cord-Derived Wharton`s Jelly for Regenerative Medicine Applications: A Systematic Review https://t.co/OQtxAgbJSe

Oct 27, 2021 · 1 share · 556 followers View post →
Umbilical & Placental Cell News
@Cord_Blood_News · X

Latest study from @UniSalerno: Umbilical cord-derived Wharton’s jelly for regenerative medicine applications. https://t.co/yeuCMf5FvG

Feb 21, 2020 · 2,034 followers View post →